Letrobol Tablets

BRITISH DRAGON LETROBOL

Letrobol Tablets by British Dragon is a pharmaceutical formulation containing Letrozole as the active substance. Each tablet typically provides 2.5 mg of Letrozole. Letrozole is classified as a non-steroidal aromatase inhibitor with potent anti-estrogenic properties.

DRUG COMPOSITION

Each tablet of Letrobol contains 2.5 mg of Letrozole.

PHARMACEUTICAL FORM

Letrobol is formulated in tablet form for convenient oral administration.

PHARMACEUTICAL GROUP AND ATC CODE

Pharmaceutical group: Antineoplastic and immunomodulating agents; ATC code: L02BG04.

PHARMACOLOGICAL PROPERTIES

Letrozole is an aromatase inhibitor that works by suppressing the conversion of androgens to estrogens, effectively reducing estrogen levels in postmenopausal women. It is primarily used in the treatment of hormone receptor-positive breast cancer.

PROFILE

• Chemical name: 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile
• Chemical formula: C17H11N5
• Percentage of anabolic activity: Not a steroid
• Percentage of androgenic activity: Not a steroid
• Active half life: 2 days
• Recommended dosage: 0.5-2.5 mg/day
• Acne: no
• Bloating (water retention): no
• HBR: no
• Hepatic toxicity: no
• Aromatization: no

THERAPEUTICAL INDICATIONS

Letrobol is indicated for the adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer. It is also used for the extended adjuvant treatment of early breast cancer in postmenopausal women.

DOSES AND METHOD OF ADMINISTRATION

The dosage and administration of Letrobol are individualized based on the specific needs and medical condition of the patient. It is typically taken orally once daily, with or without food.

CYCLE/STACKING

Solo cycle:

• Letrobol is commonly used as a standalone therapy for breast cancer treatment, especially in postmenopausal women.

Cutting cycle:

• Letrobol is often included in cutting cycles to manage estrogen levels and reduce the risk of estrogen-related side effects when using aromatizable anabolic steroids.

Bulking cycle:

• Letrobol may be utilized in bulking cycles to control estrogen levels, particularly when incorporating compounds that may lead to aromatization.

POST CYCLE THERAPY

Letrobol is sometimes employed in post-cycle therapy (PCT) to prevent estrogen rebound after the use of aromatizable steroids. The duration and dosage may vary.

SIDE EFFECTS

Common side effects include hot flashes, fatigue, and joint pain. Serious side effects are rare but may include bone density reduction.

CONTRAINDICATIONS

Letrobol is contraindicated in individuals with hypersensitivity to the drug. It should not be used in premenopausal women or in those with severe hepatic impairment.

OVERDOSE

There is limited information on the effects of overdose. In case of overdose, seek medical attention.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE:

Patients with a history of osteoporosis or other bone-related issues should be monitored closely. Regular bone density assessments may be recommended.

INTERACTIONS WITH OTHER DRUGS

Letrobol may interact with certain medications, and patients should inform healthcare providers of all medications being taken.

PRESENTATION, PACKAGING

2.5 mg per tablet, 50 tablets in sachet.

STORAGE

Store Letrobol in a cool, dry place, protected from light.

LEGAL STATUS

Letrobol is a prescription medication and is subject to legal regulations.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

British Dragon
Europe

EXTERNAL LINKS

• Letrozole Wiki, wikipedia.org
• Letrozole Uses, Side Effects & Warnings, drugs.com
• Letrozole Oral: Uses, Side Effects, Interactions, Pictures, medlineplus.gov.